Your browser doesn't support javascript.
loading
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohort.
Gencer, Baris; Carballo, David; Nanchen, David; Koskinas, Konstantinos C; Klingenberg, Roland; Räber, Lorenz; Auer, Reto; Carballo, Sebastian; Heg, Dik; Windecker, Stephan; Lüscher, Thomas Felix; Matter, Christian M; Rodondi, Nicolas; Mach, François.
Afiliación
  • Gencer B; Cardiology Division, Geneva University Hospitals, Switzerland; TIMI Study Group, Brigham and Women's Hospitals, Harvard Medical School, Boston, USA. Electronic address: baris.gencer@hcuge.ch.
  • Carballo D; Cardiology Division, Geneva University Hospitals, Switzerland.
  • Nanchen D; Department of Ambulatory Care and Community Medicine, Lausanne University, Switzerland.
  • Koskinas KC; Department of Cardiology, University Hospital of Bern, Switzerland.
  • Klingenberg R; Department of Cardiology, University Heart Center, University of Zurich, Switzerland.
  • Räber L; Department of Cardiology, University Hospital of Bern, Switzerland.
  • Auer R; Institute of Primary Health Care (BIHAM), University of Bern, Switzerland.
  • Carballo S; Department of Internal Medicine, Geneva University Hospitals, Switzerland.
  • Heg D; Institute of Social and Preventive Medicine, and Clinical Trials Unit, Department of Clinical Research, University of Bern, Switzerland.
  • Windecker S; Department of Cardiology, University Hospital of Bern, Switzerland.
  • Lüscher TF; Center for Molecular Cardiology, University of Zurich, Switzerland; Cardiology, Royal Brompton and Harefield Hospital and Imperial College London, United Kingdom.
  • Matter CM; Department of Cardiology, University Heart Center, University of Zurich, Switzerland; Center for Molecular Cardiology, University of Zurich, Switzerland.
  • Rodondi N; Institute of Primary Health Care (BIHAM), University of Bern, Switzerland; Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Mach F; Cardiology Division, Geneva University Hospitals, Switzerland.
Int J Cardiol ; 303: 8-13, 2020 03 15.
Article en En | MEDLINE | ID: mdl-31859113
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Simvastatina / Síndrome Coronario Agudo / Ezetimiba / LDL-Colesterol Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cardiol Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Simvastatina / Síndrome Coronario Agudo / Ezetimiba / LDL-Colesterol Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cardiol Año: 2020 Tipo del documento: Article